Østfold Hospital Trust is a health trust in Norway with bases in Fredrikstad, Moss, Sarpsborg and Halden. It is owned by Southern and Eastern Norway Regional Health Authority.

During the past decade, Ostfold Hospital Trust conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ostfold Hospital Trust" #1 sponsor was "Ostfold Hospital Trust" with 7 trials, followed by "Oslo University Hospital" with 4 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Leiden University Medical Center" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ostfold Hospital Trust" #1 collaborator was "Haukeland University Hospital" with 4 trials as a collaborator, "St. Olavs Hospital" with 3 trials as a collaborator, "University Hospital of North Norway" with 3 trials as a collaborator, "University Hospital, Akershus" with 3 trials as a collaborator and "Helse Stavanger HF" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Ostfold Hospital Trust" are "Pain, Postoperative" (2 trials), "Central Retinal Artery Occlusion" (1 trials), "Cheyne Stokes Respiration" (1 trials), "Cholecystectomy" (1 trials) and "Cholecystitis" (1 trials). Many other conditions were trialed in "Ostfold Hospital Trust" in a lesser frequency.

Most popular intervention types in "Ostfold Hospital Trust" are "Drug" (7 trials), "Other" (6 trials), "Procedure" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ASV" (1 trials), "Biosimilar Infliximab" (1 trials), "Cholecystectomy" (1 trials) and "Daratumumab Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ostfold Hospital Trust" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Ostfold Hospital Trust". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Ostfold Hospital Trust, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ostfold Hospital Trust, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".